Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 17 (7), 962-9

Sleeve Gastrectomy for Morbid Obesity

Affiliations
Review

Sleeve Gastrectomy for Morbid Obesity

Andrew A Gumbs et al. Obes Surg.

Abstract

The rising prevalence of morbid obesity and the increased incidence of super-obese patients (BMI >50 kg/m2) seeking surgical treatments has led to the search for surgical techniques that provide adequate EWL with the least possible morbidity. Sleeve gastrectomy (SG) was initially added as a modification to the biliopancreatic diversion (BPD) and then combined with a duodenal switch (DS) in 1988. It was first performed laparoscopically in 1999 as part of a DS and subsequently done alone as a staged procedure in 2000. With the revelation that patients experienced weight loss after SG, interest in using this procedure as a bridge to more definitive surgical treatment has risen. Benefits of SG include the low rate of complications, the avoidance of foreign material, the maintenance of normal gastro-intestinal continuity, the absence of malabsorption and the ability to convert to multiple other operations. Reduction of the ghrelin-producing stomach mass may account for its superiority to other gastric restrictive procedures. SG should be in the armamentarium of all bariatric surgeons. Nonetheless, long-term studies are necessary to see if it is a durable procedure in the treatment of morbid obesity.

Similar articles

See all similar articles

Cited by 111 articles

See all "Cited by" articles

References

    1. Obes Surg. 2006 Nov;16(11):1425-32 - PubMed
    1. Obes Surg. 2006 Nov;16(11):1445-9 - PubMed
    1. Obes Surg. 2007 May;17(5):565-8 - PubMed
    1. Obes Surg. 2006 Sep;16(9):1138-44 - PubMed
    1. Diabetes Obes Metab. 2001 Apr;3(2):99-103 - PubMed

Publication types

Feedback